Product information

Current status:

Marketed

Current status date:

2013-04-20

Original market date: ^{See footnote 1}

1950-12-31

Product name:

NEO-LARYNGOBIS

DIN:

00065927 Electronic product monograph is not available

Company:

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Suppository

Route(s) of administration:

Rectal

Number of active ingredient(s):

1

Schedule(s):

OTC

American Hospital Formulary Service (AHFS): ^{See footnote 3}

52:92.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

R02AA20 VARIOUS

Active ingredient group (AIG) number:^{See footnote5}

0108681002